Brief: Oncopeptides Q3 Oper Loss Narrows To SEK 88.9 Mln
Nov 9 (Reuters) - Oncopeptides AB ONCO.ST :
* ONCOPEPTIDES AB Q3 NET SALES SEK 0 MILLION VERSUS SEK 54.3
MILLION YEAR AGO
* Q3 OPERATING LOSS SEK 88.9 MILLION VERSUS LOSS SEK 338.9
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr521HQf
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy